TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive Karkin, Hatfield Vow to Amend Health Reform To Include Trust Fund For Medical Research June 4, 1993
TCL Archive In Brief: Treatment Reorganization Plan Due In November, Rauscher Says; Panel To Review Clinical Activities June 27, 1975